Skip to main content

He Xu, MD

Assistant Professor of Surgery

Education and Training

  • Research Fellowship, Transplantation Branch, National Institutes of Health, 1999 - 2001
  • Surgical Research Fellowship, Surgery, Loma Linda University, 1995 - 1997
  • Postdoctoral Research Scientist, Surgery, Columbia University, 1991 - 1992
  • PostdoctoralResearch Fellow, Surgery, Columbia University, 1988 - 1990
  • Cardiothoracic Fellowship, Surgery, Capital Institute of Medicine (China), 1986 - 1988
  • Resident, Surgery, Capital Institute of Medicine (China), 1983 - 1986
  • M.D., Hebei Medical College (China), 1983

Publications

Schmitz, Robin, Zachary W. Fitch, He Xu, Ada Ghali, Aneesh K. Mehta, Antonio Guasch, and Allan D. Kirk. “Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up.” Am J Transplant, June 8, 2020. https://doi.org/10.1111/ajt.16121.

Full Text

Xu, He, Aneesh K. Mehta, Qimeng Gao, Hui-Jie Lee, Ada Ghali, Antonio Guasch, and Allan D. Kirk. “B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen.” Am J Transplant 20, no. 3 (March 2020): 653–62. https://doi.org/10.1111/ajt.15639.

Full Text

Lin, Liwen, He Xu, Muath Bishawi, FeiFei Feng, Kannan Samy, George Truskey, Andrew S. Barbas, Allan D. Kirk, and Todd V. Brennan. “Circulating mitochondria in organ donors promote allograft rejection.” Am J Transplant 19, no. 7 (July 2019): 1917–29. https://doi.org/10.1111/ajt.15309.

Full Text

Xu, He, Victoria A. Bendersky, Todd V. Brennan, Jaclyn R. Espinosa, and Allan D. Kirk. “IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection.” Am J Transplant 18, no. 3 (March 2018): 720–30. https://doi.org/10.1111/ajt.14589.

Full Text

Xu, Hanzhang, Truls Ostbye, Allison A. Vorderstrasse, Matthew E. Dupre, and Bei Wu. “Place of Residence and Cognitive Function among the Adult Population in India.” Neuroepidemiology 50, no. 3–4 (2018): 119–27. https://doi.org/10.1159/000486596.

Full Text

Manook, M., J. Kwun, C. Burghuber, K. Samy, M. Mulvihill, J. Yoon, H. Xu, et al. “Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.” Am J Transplant 17, no. 8 (August 2017): 2055–64. https://doi.org/10.1111/ajt.14234.

Full Text

Xu, H., K. P. Samy, A. Guasch, S. I. Mead, A. Ghali, A. Mehta, L. Stempora, and A. D. Kirk. “Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients.” Am J Transplant 16, no. 2 (February 2016): 550–64. https://doi.org/10.1111/ajt.13469.

Full Text

Kirk, A. D., A. Guasch, H. Xu, J. Cheeseman, S. I. Mead, A. Ghali, A. K. Mehta, et al. “Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.” Am J Transplant 14, no. 5 (May 2014): 1142–51. https://doi.org/10.1111/ajt.12712.

Full Text

Xu, H., S. D. Perez, J. Cheeseman, A. K. Mehta, and A. D. Kirk. “The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation.” Am J Transplant 14, no. 2 (February 2014): 319–32. https://doi.org/10.1111/ajt.12574.

Full Text

Zhu, L. M., Y. S. Fang, Z. G. Sun, L. Z. Yu, and H. Xu. “Monocyte-derived CD40 expression is regulated by interferon-γ/interferon-γ receptor-1 pathway when acting as a bridge during their interaction with T cells and allogeneic endothelial cells.” In Transplantation Proceedings, 44:996–98, 2012. https://doi.org/10.1016/j.transproceed.2012.01.096.

Full Text

Pages